Rayner
Gabriela Spinola, MEng, AMIChemE has a diverse range of work experience in engineering and project management. Gabriela is currently the Head of Engineering at Rayner since joining in 2017. In this role, Gabriela is responsible for leading the restructuring of the Engineering department to align with the company's 5-year strategic vision. Gabriela manages two work streams: Advanced Engineering, which focuses on implementing capital projects, new product introduction, and cost-saving initiatives, and Sustaining Engineering, which supports day-to-day production activities.
Prior to their current role, Gabriela worked as a Process Engineering Manager at Rayner, where they led the restructure of the Engineering department and managed strategic planning, resource allocation, recruitment, and training. Gabriela also served as a Manufacturing Engineer at Rayner, where they successfully managed a cost-saving project and implemented a new production area using innovative technology.
Before joining Rayner, Gabriela worked as a Process/Project Engineer at GSK. In this role, they led a team in completing improvement projects for a fermentation plant and a solvent extraction plant. Gabriela was responsible for project and planning management, resource planning, and ensuring compliance with validation timelines.
Gabriela also gained experience as a Project Manager and Assistant Project Manager at Mace, where they worked in the pharmaceutical and technology sectors. In these roles, Gabriela demonstrated strong management and communication skills, working across functions and maintaining good relationships with clients. Gabriela also underwent CPD training courses in presentation and communication skills and influential leadership.
Gabriela's early work experience includes a summer internship at the University of Manchester, where they gained skills in biotechnology, chromatography, and spectrophotometry. Gabriela also completed a feasibility study on biobutanol production.
Overall, Gabriela Spinola has a strong background in engineering leadership, project management, and process improvement in various industries.
Gabriela Spinola pursued their education with a focus on Chemical Engineering. Gabriela obtained an Engineer's degree from Universidade Estadual de Campinas in 2012. Following this, they enrolled at The University of Manchester and completed their Master of Engineering (MEng) degree in Chemical Engineering in 2015.
This person is not in any offices
Rayner
5 followers
Rayner designs and manufactures intraocular lenses and proprietary injection devices for use in cataract surgery. When Sir Harold Ridley designed the world’s first IOL in 1949, he chose Rayner to manufacture this ground-breaking invention.With more than 65 years of continuous growth and experience, we remain at the forefront of innovation. Weare focused on providing the best IOLs for clinicians and patients and are driven by science to improve patient outcomes and safety.Primary IOLs Our FDA-approved C-flex aspheric (aberration-neutral) monofocal IOL, as well as our toric and multifocal IOL families are now complemented by the RayOne fully preloaded monofocal IOL injection system. Supplementary IOLsDesigned to be implanted in the ciliary sulcus, Rayner Sulcoflex Pseudophakic Supplementary IOLs are available as aspheric, toric, multifocal and multifocal lenses, and offer a reversible solution for correcting residual post-operative refractive errors following the implantation of a conventional IOL in the capsular bag.OVDsOur Ophteis range offers a full spectrum of OVDs from dispersive to cohesive, enabling surgeons to select the OVD best suited to each specific cataract procedure. Ophteis FR Pro with sorbitol -- designed to deliver a new level of corneal endothelial protection from phaco induced trauma -- is the flagship product of Rayner’s ‘Ophteis’ OVD suite. PharmaceuticalsAlthough the intraocular lens plays a leading role in the visual outcomes of cataract and refractive surgery, the pharmaceuticals that manage the tear film and inflammation are critical to the end result. For that reason, Rayner recently acquired the business of Moorfields Pharmaceuticals. The acquisition will enable us to offer an even wider range of ophthalmic tools that aid and streamline the surgical process whilst remaining focused on the visual outcome for the patient.Rayner markets its IOL portfolio and related products worldwide through a network of distributors in over 80 countries with direct markets in UK, Germany & Austria, the United States of America, Italy and Spain. We have the world’s longest commercial history of IOL design and manufacturing and have worked with cataract surgeons for longer than anyone else.In 2016, Rayner transferred its global headquarters to a brand new state of the art manufacturing plant, which has dramatically increased the company’s production capacity.